dpp-4 inhibitors vs. glp-1 agonist dpp 4 vs glp 1 analogues and inhibitors in type 2 diabetes therapy: from structural biology to clinics How does sitagliptin work? DPP-4

Up to 80% of patients treated with taxanes reported some extent of neuropathy, and about 25% to 30% reported severe neuropathy[]

Cholinergic hypothesis states that the degeneration of basal forebrain neurons in AD patients leads to dysfunction and death of cholinergic neurons in the forebrain, followed by extensive presynaptic denervation occurs, and the loss of specific subtypes of acetylcholine receptors, leading to cognitive decline in AD patients (39)

10.1001/jamainternmed.2024.4369 Summary Keywords cardiovascular disease, cardiovascular outcome, glucagon-like peptide-1 receptor agonists, heart failure, obesity Citation Turkistani Y (2025) Glucagon-like peptide-1 receptor agonists: a review from a cardiovascular perspective

Overall, these results highlight the regulation of G6PD protein during the infection by NRF2 and underscore the interrelationship between glucose metabolism and susceptibility to viral infections during glucose metabolic alterations, supporting the central role of G6PD pathway modulation

Collaborative care models enhance lifestyle interventions by focusing on diet, exercise, and foot care, essential for preventing complications such as diabetic foot ulcers